GlycoMimetics (GLYC)
(Delayed Data from NSDQ)
$1.64 USD
-0.07 (-4.09%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.76 +0.12 (7.32%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Brokerage Reports
0 items in cart
GlycoMimetics, Inc. [GLYC]
Reports for Purchase
Showing records 141 - 157 ( 157 total )
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
Future AML Label Breadth Manifesting; Reiterating Buy - Raising PT to $35
Provider: Roth Capital Partners, Inc.
Analyst: MARANGO J
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
The Brave New World of AML
Provider: Roth Capital Partners, Inc.
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
Through the AML Looking-Glass; Initiating with Buy and $25 PT
Provider: Roth Capital Partners, Inc.